by Laurie B. Rosenblum, MPH
A pulmonary embolism (PE) is a blockage in a blood vessel of the lungs. The blood vessel is an artery that brings fresh blood to the lung tissue. The PE blocks the flow of blood to an area of the lungs. Lung tissue will begin to die without blood flow. The dead tissue will make it difficult for the lungs to work properly. In severe cases, a PE can lead to death.
An embolus is a lump that is floating in the blood. It is usually made of a blood clot. Some can also be made of an air bubble, a piece of fat, bone marrow, or tumor tissue. The embolus travels through the blood until it gets stuck in a smaller blood vessel. This is when it become an embolism. In this case, it is trapped in an artery of the lungs.
A blood clot embolus that lands in the lung often comes from the legs or pelvis.
Factors that may increase your chance of PE include:
The symptoms of PE will depend on the size and location of the blockage. The amount of lung tissue that has reduced blood flow will also affect the symptoms. PE may cause:
Your doctor will ask about your symptoms and medical history. A physical exam will be done. Your doctor may order the following tests:
Images of the lungs and heart may be taken with:
Treatment will depend on the size of the clot and how severe your symptoms are. Emergency treatment may be needed.
Emergency treatment may include:
Medicine may be all that is needed for less severe PEs. The medicine will help to break up the clot and keep new ones from forming.
Thrombolytics are a type of medicine that can dissolve a clot. It is only used in people with a very large PE that is causing severe illness. This type of medicine can cause sudden severe bleeding. It cannot be used in people with a high risk of bleeding.
Anticoagulants (blood thinners) will make it hard for blood to form clots. They will keep the clot from getting bigger and prevent new clots from forming. The body will be able to break up the clot after some time. This option may be used for smaller PEs that are not causing major symptoms. Medicine may need to be taken long term to prevent future blood clots and PEs.
Surgery to remove the clot may be needed if one or more of the following is present:
The surgery is called an embolectomy.
A filter will be placed inside a large vein in the abdomen. This filter can catch blood clots that leave the lower body. It will trap the clots before they reach the lungs.
The filter is used for people that have frequent blood clots. It may be needed for people who have not had a good response to other treatment. It may also be an option for those who cannot take blood thinners.
Lowering the risk of blood clots in the legs can decrease the risk of PE.
In addition, people at high risk of developing blood clots should:
American Lung Association
American Society of Hematology
Wärntges S, Konstantinides S. Progress in the management of acute pulmonary embolism. Curr Opin Pulm Med. 2015 Sep;21(5):417-24.
Philbrick JT, Shumate R, Siadaty MS, Becker DM. Air travel and venous thromboembolism: a systematic review. J Gen Intern Med. 2007;22(1):107-114.
Pulmonary embolism (PE). EBSCO DynaMed Plus website. Available at: http://www.dynamed... . Updated July 7, 2017. Accessed August 25, 2017.
Pulmonary embolism. Society for Vascular Surgery website. Available at: https://vascular.org/patient-resources/vascular-conditions/pulmonary-embolism. Accessed August 25, 2017.
10/5/2010 DynaMed Plus Systematic Literature Surveillance http://www.dynamed... : Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ. 2010;341:c4245.
12/17/2010 DynaMed Plus Systematic Literature Surveillance http://www.dynamed... : Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375(9715):657-663.
1/26/2012 DynaMed Plus Systematic Literature Surveillance http://www.dynamed... : Zöller B, Li X, Sundquist J, Sundquist K. Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet. 2012;379(9812):244-249.
Last reviewed September 2018 by EBSCO Medical Review Board Michael Woods, MD, FAAP
Last Updated: 4/24/2018
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.